Relationship between receipt of substitutable for-fee vaccines and completion of the expanded programme on immunisation: a cross-sectional study in Fujian, China

Wu, Jiang‐Nan; Li, Da‐Jin; Yong, Zhou; Du, Meirong; Piao, Hailan

doi:10.1136/bmjopen-2016-015666

Cited by 5 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…China has now expanded NIP (including one dose of Bacille Calmette-Guerin vaccine, four doses of the oral live attenuated polio vaccine, etc.) and NIP vaccination rates have reached high levels ( 12 ). On the contrary, although non-NIP vaccines play an important role as a supplement or limited alternative to NIP in controlling the corresponding infectious diseases and meeting the health needs of different populations, the voluntary and out-of-pocket nature of non-NIP results in a low vaccination rate ( 13 ).…”

Section: Introductionmentioning

confidence: 99%

Parental preference for Haemophilus influenzae type b vaccination in Zhejiang Province, China: A discrete choice experiment

Wang

Feng²,

Zhang³

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundChina is the only country in the world that has not included the Haemophilus influenzae type b (Hib) vaccine in its National Immunization Program, making it more difficult to eliminate Hib-related diseases through Hib vaccination. It is necessary to study parental preferences for Hib vaccination to optimize vaccine promotion strategies in China.ObjectiveThis study aimed to investigate Chinese parental preference for five attributes of Hib vaccination, i.e., the place of origin, effectiveness, adverse event, doctors' recommendation, and the price of full vaccination when making a decision to vaccinate their children under 2 years old.MethodsA cross-sectional survey was conducted in two cities in Zhejiang Province from November to December in 2020 using a discrete choice experiment (DCE). A mixed logit model was used to estimate participating parents' preference for Hib vaccination attributes included in the DCE. Subgroup analysis and probability analysis were also conducted to capture the heterogeneity and trade-off of parental preference for Hib vaccination.ResultsData from 6,168 observations were included in the analyses. Parents of children are, on average, more likely to voice a positive preference for Hib vaccination. Such attributes of Hib vaccination as effectiveness and doctor's recommendation have a significant positive influence on parents' preference for Hib vaccination, while imported vaccines, adverse events, and the price of full vaccination have a significant negative influence on parents' preference. Parents with different demographic characteristics also existed heterogeneities in preference for Hib vaccination. Parents will make a trade-off on price if the Hib vaccine has a good performance on effectiveness and safety.ConclusionThe study found that, regardless of the place of origin of the Hib vaccine, parents with children under 2 years old prefer to compromise on price if the vaccine has a better effectiveness and safety profile. A proactive recommendation from doctors would strengthen their willingness for Hib vaccination. These findings help aid the development of communication strategies with parents for Hib vaccination in China.

show abstract

Section: Introductionmentioning

confidence: 99%

Parental preference for Haemophilus influenzae type b vaccination in Zhejiang Province, China: A discrete choice experiment

Wang

Feng²,

Zhang³

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…However, there are still some barriers in improving the coverage and effectiveness of hepatitis B vaccination, such as a delay of the hepatitis B vaccine first dose, the impact of substitutable vaccine, immune failure, and cost of maternal antiviral treatment. 16–19 , 20 , 21 , 22 , 23 In addition, the decline in hepatitis B awareness is one of the challenges for the prevention and control of HBV infection in China. 16 , 24 In the present study, we identified that hepatitis B awareness has declined since the inclusion of hepatitis B into the national immunization program in 1992.…”

Section: Discussionmentioning

confidence: 99%

Association of vaccine policy with virus infection and awareness of hepatitis B in Fujian, China

Huang

Lin

Yang

et al. 2022

Human Vaccines & Immunotherapeutics

Self Cite

View full text Add to dashboard Cite

China has regulated its hepatitis B vaccination policy. However, data on the prevalence of hepatitis B virus (HBV) infection have not been updated since 2014. In addition, the impact of the policy on awareness of hepatitis B is limited, especially in Fujian Province where HBV infection is highly prevalent. We conducted a sero-epidemiological survey in five national monitoring counties to address these concerns. A total of 5,873 subjects were included and classified into four birth cohorts according to the policy time nodes (1981, 1992, and 2002). The HBsAg carrier rate for the general population was 8.6% (95% confidence interval [CI]: 7.9–9.3). Compared with those born before 1981, adjusted odds ratios (OR) for HBV infection were 0.51 (95% CI: 0.43–0.62), 0.10 (0.08–0.12), and 0.015 (0.01–0.023) among the 1981–1991, 1992–2001, and ≥2002 birth cohorts, respectively; while the OR was 1.26 (1.00–1.57), 0.39 (0.26–0.58), and 0.019 (0.006–0.06) for HBsAg carriage, respectively. Among the 4865 residents aged ≥15 years, hepatitis B awareness has been declining since the introduction of the hepatitis B vaccine into the immunization program (β = −0.25, SE = 0.08, P = .001, and β = −0.20, SE = 0.08, P = .017 for 1992–2001 and ≥2002 birth cohort, respectively). This decline was obvious for the initiation time of the first dose of the hepatitis B vaccine. Although the hepatitis B vaccination policies have helped reduce the infection, the awareness has declined. More measures on the target population are warranted to improve the public’s awareness of hepatitis B vaccination in the context of great achievements.

show abstract

“…Followed by "False belief regarding vaccination and cultural barriers" also mentioned by 25% (9) of studies and similarly "Cost of vaccine and unavailability of the vaccine" mentioned by 25% ( 9) of reviewed studies. The fourth most mentioned barrier is "low awareness among providers and Inadequate knowledge of HBV among health-care workers" which mentioned by 19% ( 7 1, (Butsashvili et al, 2012;Giles-Vernick et al, 2016b;Larcher et al, 2001b); 2, (Cox et al, 2012b;Fourn et al, 2009b;Ritvo et al, 2003); 3, (Butsashvili et al, 2012;Ko et al, 2017b); 4, (Branco et al, 2014;Wu et al, 2017); 5, (Han et al, 2014); 6, (Bowman et al, 2014;MacDougall et al, 2015b); 7, (Han et al, 2014;Philbin et al, 2012b);8, (Philbin et al, 2012b); 9, (Akibu et al, 2018;Butsashvili et al, 2012;Harris et al, 2007); 10, (Juon et al, 2009b;Khan & Ross, 2013;Yau et al, 2016b;Zacharias et al, 2015); 11, (Butsashvili et al, 2012;MacDougall et al, 2015b); 12, (Navarro et al, 2014); 13, (Akibu et al, 2018;MacDougall et al, 2015b;Mollema et al, 2012); 14, (Chingle et al, 2017); 15, (Akibu et al, 2018;Branco et al, 2014); 16, (Butsashvili et al, 2012;MacDougall et al, 2015b;Philbin et al, 2012b); 17, (Kabir et al, 2010); 18, (Harris et al, 2007); 19, (Han et al, 2014); 20, (Ganczak et al, 2015;…”

Section: Barriers To Utilization Of Hepatitis B Vaccinementioning

confidence: 99%

Vaccination against Hepatitis B: A Scoping Review

Mohanty

Jena

Patnaik

2020

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

Objective: Elimination of viral hepatitis by 2030 as one of the international Sustainable Development Goals puts the hepatitis B vaccination on the forefront. However, barriers to vaccination reported in various studies are of concern. This study explores the global barriers for effective uptake of Hepatitis-B vaccination. Methods: A scoping review of studies reporting hepatitis B vaccination barriers was done using PMC data base and Google scholar search engine. About 803 journal articles and reports on hepatitis B barriers were retrieved but only 36 most relevant items during last 10 years were identified, pile sorted, grouped and analyze. Results: Overall 74 barriers have been identified for effective uptake of hepatitis-B vaccines. Most studies focused on non-zero dose of hepatitis B vaccine, One-third of the barriers are related to system issues, one-fourth of the barriers were related to caregiver education or awareness, fear of side effect, migration etc., one-fifth barriers were related to service provider issues like poor out-reach, home visits, poor communication and/relation with the caregivers, failure to identify unimmunized children etc., and other barriers were social-cultural issues. The review reveals limited availability and accessibility to health-facility based immunization, lack of awareness among caregivers, poor communication by the healthcare workers and negative relationships with the beneficiaries, cost of vaccine in private sector, inconvenience time and place of vaccination etc. as the major barriers for hepatitis B vaccination. Barriers varied from country to country. Conclusion: Myriad barriers for reduced hepatitis-B vaccine uptake need to be addressed contextually as countries are at different stages of hepatitis-B vaccination implementation.

show abstract

Relationship between receipt of substitutable for-fee vaccines and completion of the expanded programme on immunisation: a cross-sectional study in Fujian, China

Cited by 5 publications

References 19 publications

Parental preference for Haemophilus influenzae type b vaccination in Zhejiang Province, China: A discrete choice experiment

Parental preference for Haemophilus influenzae type b vaccination in Zhejiang Province, China: A discrete choice experiment

Association of vaccine policy with virus infection and awareness of hepatitis B in Fujian, China

Vaccination against Hepatitis B: A Scoping Review

Contact Info

Product

Resources

About